Combination therapy comprising glucose reabsorption inhibitors and retinoid-X receptor modulators
US8183213B2 · kind B2 · utility
0Cited by
16References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 24, 2007 |
| Grant date | May 22, 2012 |
| Priority date | — |
| Expiry date | Jun 2, 2030 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Combination therapy comprising RXR modulators and glucose reabsorption inhibitors useful for the treatment of diabetes and Syndrome X are disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.